Overview
Copper (Cu) is an essential trace metal that plays a vital role in numerous biochemical reactions and physiological processes in the human body. In plasma, copper is largely protein-bound: approximately 65–90% is bound to ceruloplasmin, while the remaining fraction is loosely bound to albumin, transcuprein, and amino acids. This loosely bound fraction is referred to as free copper.
Under normal conditions, copper homeostasis is tightly regulated. However, excess free copper is toxic, particularly in conditions such as Wilson’s disease, where it leads to hepatic and extrahepatic tissue damage. Copper is crucial for red blood cell synthesis, iron absorption, immune system function, nerve health, collagen synthesis, and the maintenance of bones and connective tissue. It also acts as an antioxidant by reducing free radical – induced cellular and DNA damage.
Symptoms
Abnormal copper levels – either excess or deficiency – can result in a wide range of clinical manifestations. Copper poisoning may present with gastrointestinal symptoms such as nausea, vomiting (sometimes bloody), diarrhea (blue or green in color), and abdominal pain. Hepatic involvement includes jaundice, hepatitis, cirrhosis, hepatic necrosis, and liver failure.
Hematological effects include intravascular hemolysis and hemolytic anemia, while renal manifestations include acute kidney failure and nephropathy. Neurological and psychiatric symptoms may include headache, altered mental status, irritability, convulsions, and the presence of Kayser–Fleischer rings in chronic cases. Cardiovascular symptoms include hypotension, tachycardia, and cardiotoxicity. Other systemic effects include metallic taste, fever, and metal fume fever following inhalation exposure.
Causes
Copper imbalance may arise due to genetic, metabolic, hepatic, renal, or environmental factors. Genetic disorders include Wilson’s disease (hepatolenticular degeneration) caused by mutations in copper-transporting ATPase genes, and Menkes kinky hair syndrome.
Copper abnormalities are also associated with acute or chronic liver diseases such as hepatitis, cirrhosis, and Indian childhood cirrhosis. Other contributing conditions include kidney failure, rheumatoid arthritis, anemia, and the use of certain medications. Environmental and occupational exposure, particularly in industrial settings, can also lead to copper toxicity.
Risk Factors
Individuals at higher risk for copper imbalance include patients suspected of Wilson’s disease, those with excess copper storage disorders, hepatic damage, renal failure, or suspected copper poisoning. Clinical signs such as anemia, abdominal pain, dark urine, jaundice, yellowing of eyes, and Kayser–Fleischer rings further raise suspicion.
Industrial exposure to copper dusts or fumes increases the risk of respiratory irritation, metal fume fever, skin and eye irritation, allergic contact dermatitis, and environmental toxicity, particularly affecting aquatic life.
Prevention and Diagnostic Approach
Copper and ceruloplasmin are generally tested together for accurate assessment. Diagnostic evaluation includes serum copper estimation and 24-hour urinary copper analysis, which is especially useful in detecting copper overload.
Laboratory measurement methods include Atomic Absorption Spectroscopy (AAS), Inductively Coupled Plasma Mass Spectrometry (ICP-MS), iodometric, spectrophotometric, colorimetric, and titration methods.
Sample preparation guidelines include:
- 8–10 hours fasting before blood sample collection
- Discontinuation of nutritional supplements and non-essential medications under medical advice
- Collection of 3.0 ml blood in a plain red-capped tube with early serum separation
- Proper 24-hour urine collection in a plastic container with an acid preservative and refrigeration during collection
Reference ranges for serum and urinary copper vary according to age and sex. Increased copper levels are seen in conditions such as cholestasis, hepatitis, cirrhosis, and Wilson’s disease, while decreased levels occur in malnutrition, hypoproteinemia, nephrotic syndrome, and Menkes disease.
Clinical Significance
Copper estimation has significant diagnostic utility. Serum copper and ceruloplasmin levels help diagnose Wilson’s disease and Menkes disease and differentiate copper-related metabolic and neuropsychiatric disorders. Urinary copper testing aids in assessing copper overload and toxicity. Copper also has applications in toxicological screening, metabolic evaluation, and advanced imaging techniques using radioisotopes in specialized settings.
